Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Frontiers in Aging Neuroscience
|
February 8, 2021
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review
Clara Sanches, Chloé Stengel, Juliette Godard, et al.
Neurology
|
July 5, 2019
Language boosting by transcranial stimulation in progressive supranuclear palsy
Antoni Valero-Cabré, Clara Sanches, Juliette Godard, et al.
Annals of Neurology
|
August 25, 2016
Direct current stimulation over the anterior temporal areas boosts semantic processing in primary progressive aphasia
Marc Teichmann, Constance Lesoil, Juliette Godard, et al.
Future Oncology (London, England)
|
October 7, 2025
IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer
Taofeek K Owonikoko, Lauren Byers, Ying Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2025
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial
Charles M Rudin, Melissa L Johnson, Luis Paz-Ares, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Frontiers in Aging Neuroscience
|
February 8, 2021
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review
Clara Sanches, Chloé Stengel, Juliette Godard, et al.
Neurology
|
July 5, 2019
Language boosting by transcranial stimulation in progressive supranuclear palsy
Antoni Valero-Cabré, Clara Sanches, Juliette Godard, et al.
Annals of Neurology
|
August 25, 2016
Direct current stimulation over the anterior temporal areas boosts semantic processing in primary progressive aphasia
Marc Teichmann, Constance Lesoil, Juliette Godard, et al.
Future Oncology (London, England)
|
October 7, 2025
IDeate-Lung02: a Phase 3 study of second-line ifinatamab deruxtecan in patients with relapsed small cell lung cancer
Taofeek K Owonikoko, Lauren Byers, Ying Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2025
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial
Charles M Rudin, Melissa L Johnson, Luis Paz-Ares, et al.
Page
of 1